Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier
- Vol. 85 (9) , 1100-1105
- https://doi.org/10.1016/s0002-9149(00)00703-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled TrialJournal of Cardiovascular Pharmacology and Therapeutics, 1996
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Efficacy and Safety of Controlled-Release Niacin in Dyslipoproteinemic VeteransAnnals of Internal Medicine, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Differential effects of nicotinic acid in subjects with different LDL subclass patternsAtherosclerosis, 1992
- Hepatic toxicity of unmodified and time-release preparations of niacinThe American Journal of Medicine, 1992
- Niacin and Hepatic FailureAnnals of Internal Medicine, 1989
- Effect of Low-Dose Niacin on High-Density Lipoprotein Cholesterol and Total Cholesterol/High-Density Lipoprotein Cholesterol RatioArchives of internal medicine (1960), 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985